Latest filing published 15 Sept 2026 for Revolution Medicines, Inc., €2.4M.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Goldsmith Mark A: trading record in brief
Goldsmith Mark A is a declared insider of Revolution Medicines, Inc., with filings sourced from SEC (Form 4). We count 2 filings; the first trade dates from 15 June 2026 and the latest from 15 September 2026.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
Most recently, on 15 September 2026, the filings show a transaction worth €2.4M in Revolution Medicines, Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Goldsmith Mark A
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 13,603 shares@ US$203.77Common StockSEC144:0001246842-26-000006
- 9,772 shares@ US$153.875.5% of flowCommon StockSEC144:0001246842-26-000002
2 of 2 declarations
